Standard Chem & Pharm CO., LTD.

Taiwan Stock Exchange 1720.TW

Standard Chem & Pharm CO., LTD. Price to Book Ratio (P/B) on January 14, 2025: 1.92

Standard Chem & Pharm CO., LTD. Price to Book Ratio (P/B) is 1.92 on January 14, 2025, a -11.20% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Standard Chem & Pharm CO., LTD. 52-week high Price to Book Ratio (P/B) is 63.46 on December 20, 2024, which is 3,207.08% above the current Price to Book Ratio (P/B).
Standard Chem & Pharm CO., LTD. 52-week low Price to Book Ratio (P/B) is 1.90 on January 13, 2025, which is -1.09% below the current Price to Book Ratio (P/B).
Standard Chem & Pharm CO., LTD. average Price to Book Ratio (P/B) for the last 52 weeks is 2.39.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Taiwan Stock Exchange: 1720.TW

Standard Chem & Pharm CO., LTD.

CEO	Mr. Tzu-Ting Fan
IPO Date	Jan. 4, 2000
Location	Taiwan
Headquarters	No. 6-20, Tuku
Employees	1,130
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years